Learn more

KRKA TOVARNA ZDRAVIL D D

Overview
  • Total Patents
    44
About

KRKA TOVARNA ZDRAVIL D D has a total of 44 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Germany, Serbia and Slovenia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GUANGZHOU REGENEX CORP, NFLECTION THERAPEUTICS INC and BIOMARIN IGA LTD.

Patent filings per year

Chart showing KRKA TOVARNA ZDRAVIL D Ds patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zupancic Silvo 12
#2 Stimac Anton 9
#3 Zupet Rok 9
#4 Gnidovec Joze 9
#5 Vrecer Franc 8
#6 Pisek Robert 8
#7 Breznik Marjanca 6
#8 Kramar Andrejka 5
#9 Kincl Maja 5
#10 Kotar-Jordan Berta 5

Latest patents

Publication Filing date Title
SI22839A Synthesis of duloxetine and its pharmaceutically acceptable salts by using the procedure of asymmetric transfer hydrogenation
SI22571A Stable solid pharmaceutical preparation which includes candesartan orits pharmaceutically acceptable forms
SI22572A Stable solid pharmaceutical composition which comprises candesartan or its pharmaceutically acceptable forms
SI22585A Procedure for preparation of telmisartan
DE102004060412A1 New isopropanol and water mixed solvate of olanzapine used to prepare any other solvate and/or hydrate forms of olanzapine, or anhydrous forms of olanzapine
DE102004036641A1 Delayed release pharmaceutical composition containing venlafaxine
DE102004034043A1 Solid pharmaceutical composition containing mirtazapine
DE102004028940A1 Orally disintegrating pharmaceutical composition containing risperidone
DE102004019845A1 Solid composition used as acetyl cholinesterase inhibitor comprises perindopril, microcrystalline cellulose, inorganic carbonate and other components
SI21746A Crystal forms of olanzapine and processes for their preparation
DE102004005186B3 Process for the preparation of purified ciprofloxacin
DE102004005009A1 Delayed release pharmaceutical composition of indapamide
DE10359154A1 Process for the preparation of venlafaxine and venlafaxine hydrochloride Form I
DE10337773A1 Crystallization of solid forms of clopidogrel addition salts
DE10333497A1 Sustained release composition useful in the treatment of e.g. benign prostatic hyperplasia comprises Tamsulosin core with a coating containing combination of polyvinyl acetate and polyvinyl pyrrolidone
DE10329812A1 Sustained release composition useful in the treatment of e.g. benign prostatic hyperplasia comprises Tamsulosin core with a coating containing combination of polyvinyl acetate and polyvinyl pyrrolidone
DE10301923B3 Process and intermediates for the production of olanzapine
SI9800057A Process for production of simvastatine and its derivatives